Pharming Group N.V. (AMS: PHARM)
Netherlands
· Delayed Price · Currency is EUR
0.762
+0.001 (0.13%)
Oct 8, 2024, 1:36 PM CET
Pharming Group Revenue
Pharming Group had revenue of $74.09M USD in the quarter ending June 30, 2024, with 34.97% growth. This brings the company's revenue in the last twelve months to $277.56M, up 34.54% year-over-year. In the year 2023, Pharming Group had annual revenue of $245.32M with 19.30% growth.
Revenue (ttm)
$277.56M
Revenue Growth
+34.54%
P/S Ratio
1.95
Revenue / Employee
$726.59K
Employees
382
Market Cap
515.89M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | 189.39M | 54.26M | 40.15% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Galapagos NV | 261.40M |
ASML Holding N.V. | 25.44B |
Unilever PLC | 60.29B |
Prosus N.V. | 5.07B |
RELX PLC | 10.97B |
ING Groep N.V. | 19.58B |
Pharming Group News
- 12 days ago - Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) - GlobeNewsWire
- 4 weeks ago - Pharming Group to participate in September investor conferences - GlobeNewsWire
- 2 months ago - Pharming Group NV (PHAR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Pharming Group reports second quarter and first half 2024 financial results and provides business update - GlobeNewsWire
- 2 months ago - Pharming Group to report second quarter and first half 2024 financial results on August 1 - GlobeNewsWire
- 4 months ago - Pharming Group to participate in June investor conferences - GlobeNewsWire
- 4 months ago - Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - GlobeNewsWire
- 4 months ago - Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders - GlobeNewsWire